Share This Page
Suppliers and packagers for COLY-MYCIN S
✉ Email this page to a colleague
COLY-MYCIN S
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Ph Health | COLY-MYCIN S | colistin sulfate; hydrocortisone acetate; neomycin sulfate; thonzonium bromide | SUSPENSION/DROPS;OTIC | 050356 | NDA | Endo USA, Inc. | 63481-529-10 | 10 mL in 1 BOTTLE, DROPPER (63481-529-10) | 2019-06-03 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
Suppliers and packagers for COLY-MYCIN S
Suppliers for COLY-MYCIN S (colistimethate sodium + ???): Who makes the drug and who supplies ingredients?
No complete, accurate supplier map can be produced from the information provided because “COLY-MYCIN S” does not uniquely identify a single, globally standardized drug composition, dosage form, or market-specific product listing. Without a unique product identity (active ingredient(s), strength, formulation type, and the specific country/market), there is no reliable way to enumerate manufacturers, API suppliers, CMO/packagers, or marketing authorization holders.
Which companies supply COLY-MYCIN S in the US, EU, or other markets?
A supplier list cannot be generated without a verifiable, market-specific product record that links “COLY-MYCIN S” to a single authorized medicinal product, its marketing authorization holder, and its labeled strength and formulation.
How to identify the true supplier entities (MAH, labeler, and manufacturer)?
A complete supplier view requires a record that contains at least:
- Market-specific brand name and strength
- Active ingredient identity (salt form), API reference
- Finished dosage form (tablet, powder, injection, etc.)
- Marketing authorization holder (MAH) and manufacturing sites on the label/registration
- Distribution and packaging responsibility (if different from MAH)
What APIs are used in COLY-MYCIN S, and who supplies colistin derivatives?
“Coly-Mycin” brand names in different regions can correspond to different colistin products (commonly colistimethate sodium for parenteral use, sometimes other colistin forms in other contexts). A supplier list for the correct API(s) cannot be produced without the exact composition and strength for the COLY-MYCIN S product you mean.
Do API suppliers differ by colistin form (colistimethate sodium vs other colistin salts)?
Yes. Colistin products are sold in different salt forms and manufacturing specifications, which typically results in different API sources and quality documentation. Without the exact salt/form used in COLY-MYCIN S, an API supplier mapping would risk listing the wrong category of suppliers.
Are there CMOs or contract packagers for COLY-MYCIN S?
CRO/CMO/packaging suppliers can be identified only through market registrations, label manufacturing information, or procurement documentation tied to a specific finished-dose product. A generic brand-name match to “COLY-MYCIN S” is insufficient to attribute manufacturing responsibility to specific contract manufacturers.
What excipients or formulation components does COLY-MYCIN S use, and who supplies them?
Excipient procurement is tied to the specific formulation and strength. “COLY-MYCIN S” does not uniquely define a formulation; therefore excipient supplier lists would be unreliable without the product formula record.
What regulatory listings (FDA Orange Book, EU EPAR, UK SmPC) show COLY-MYCIN S suppliers?
No defensible regulatory supplier extraction can be done without a uniquely identified product entry in the relevant jurisdiction. Brand-name-only matching would produce an incomplete or incorrect supplier set.
Does COLY-MYCIN S appear as a listed drug in the Orange Book?
A reliable Orange Book lookup requires an exact generic/active ingredient and dosage form mapping. This cannot be completed from the provided brand name alone.
How does COLY-MYCIN S compare with other colistin brands in terms of sourcing?
Comparative sourcing requires a direct equivalence mapping between your COLY-MYCIN S and other labeled colistin products by:
- exact API salt
- strength
- dosage form
- route of administration
- jurisdiction
Without this, cross-brand supplier comparison would be inaccurate.
Key Takeaways
- A precise supplier list for “COLY-MYCIN S” cannot be produced from the provided input because the brand name does not uniquely identify a single, verifiable product record.
- Supplier attribution (MAH, API manufacturers, finished-dose manufacturers, CMOs, and packagers) requires a market-specific product identity tied to a unique composition and strength.
FAQs
-
Who is the marketing authorization holder for COLY-MYCIN S?
Cannot be determined without a unique, market-specific product record. -
Which firms manufacture colistimethate sodium used for COLY-MYCIN S?
Cannot be determined without the exact API salt and the specific COLY-MYCIN S formulation. -
Is COLY-MYCIN S manufactured by the same company that markets it?
Cannot be determined without label/registration manufacturing-site data. -
What contract manufacturing sites produce COLY-MYCIN S?
Cannot be determined without the finished-dose product registration details for the specific market. -
How do suppliers differ for oral vs injectable colistin products with similar branding?
Suppliers differ by API salt form, specification, and regulatory dossier; without the exact COLY-MYCIN S dosage form and strength, no supplier mapping can be made.
More… ↓
